JP Morgan Chase’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-274,200
Closed -$13M 6416
2020
Q4
$13M Buy
+274,200
New +$12.7M ﹤0.01% 1986

Other funds holding ZYME

JP Morgan Chase's ZYME Position: Q1 2026 in Review

JP Morgan Chase increased its Zymeworks (ZYME) stake by 226% in Q1 2026, buying an estimated $1.87M and bringing the position to 114,072 shares worth $2.76M. The position accounts for ﹤0.01% of the portfolio, ranked #3852.

JP Morgan Chase first reported a position in ZYME in Q1 2019 and has held it in 26 quarters since. The position peaked at $5.54M in Q2 2025. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • JP Morgan Chase held 114,072 shares of Zymeworks worth $2.76M as of Q1 2026.
  • JP Morgan Chase bought 79,064 Zymeworks shares in Q1 2026, an estimated $1.87M.
  • Zymeworks made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #3852 holding.
  • JP Morgan Chase first reported a position in Zymeworks in Q1 2019 and has held it in 26 quarters since.
  • JP Morgan Chase's Zymeworks position peaked at $5.54M in Q2 2025.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.